Selective expression of SOX4 protein by Germinal Center B-cell like Diffuse Large B-cell Lymphoma

Malene Krag Kjeldsen(Chr. Hansen (Denmark)), Karen Dybkær(Aalborg University Hospital), Hans Erik Johnsen(Herlev Hospital), Julie Støve Bødker(Chr. Hansen (Denmark)), Martin Bøgsted(Chr. Hansen (Denmark)), Finn Skou Pedersen(Aarhus University), Preben Johansen(Chr. Hansen (Denmark)), Michael Gaihede(Chr. Hansen (Denmark)), Niels H. H. Heegaard(Statens Serum Institut), Steffen Falgreen Larsen(Aalborg University Hospital), Anders Ellern Bilgrau(Chr. Hansen (Denmark)), Alexander Schmitz(Chr. Hansen (Denmark))

VBN Forskningsportal (Aalborg Universitet)

January 1, 2013

Cited by 0

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

|Blood|2009|390

CSF biomarker variability in the Alzheimer's Association quality control program

|Alzheimer s & Dementia|2013|386

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362